CADL Competitors & Alternatives
Compare Candel Therapeutics Inc with similar stocks in the same industry
Biotechnology
CADL
Main Stock$8.51
Tradestie Score
60
Market Cap
$304.12M
Analyst Upside
+130.6%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TBPH
Theravance Biopharma, Inc.
|
$16.29
|
$726.21M | 7.4 | 61 | Compare |
|
ANL
ANL
|
$9.95
|
$725.12M | - | 52 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$14.64
|
$718.62M | - | 57 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$26.64
|
$715.25M | - | 56 | Compare |
|
EVMN
EVMN
|
$19.92
|
$710.64M | - | 52 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$108.67
|
$699.30M | - | 57 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.29
|
$688.47M | - | 53 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.00
|
$665.30M | - | 55 | Compare |
More CADL Analysis
Data updated: Jun 06, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry